Hypertensive disease and ACE-inhibitors: potential for modern therapy
Sardella, F.
Cardiologia 34(6): 489-497
1989
ISSN/ISBN: 0393-1978 PMID: 2676167 Document Number: 329163
Document emailed within 1 workday
Related Documents
Springer, C.J.; Bavetsias, V.; Jackman, A.L.; Boyle, F.T.; Marshall, D.; Pedley, R.B.; Bisset, G.M. 1996: Prodrugs of thymidylate synthase inhibitors: potential for antibody directed enzyme prodrug therapy (ADEPT) Anti-Cancer Drug Design 11(8): 625-636Bojić, I.; Mijusković, P. 1993: Modern therapy of Lyme disease GLAS. Srpska Akademija Nauka i Umetnosti. Odeljenje Medicinskih Nauka 43: 257-262
Di Napoli, M.; McLaughlin, B. 2005: The ubiquitin-proteasome system as a drug target in cerebrovascular disease: therapeutic potential of proteasome inhibitors Current Opinion in Investigational Drugs 6(7): 686-699
Ivashkin, V.T.; Trukhmanov, A.S. 2003: Modern approach to the therapy of gastroesophageal reflux disease Voenno-Meditsinskii Zhurnal 324(10): 26-34
Manfredi, R.; Monari, P.; Donzelli, C.; Furlini, G.; Re, M.C.; Chiodo, F. 1998: Protease inhibitors in antiviral therapy of paediatric HIV disease Acta Paediatrica 87(7): 814-816
Pavoncello, S.; Di Bianco, V.; Di Castro, A.; Caviglia, A.; Cellitti, M. 1980: Neurological aspects and modern trends in therapy of Parkinson's disease La Clinica Terapeutica 92(4): 433-438
Ostojić, M. 1993: Modern diagnosis and interventional therapy in ischemic heart disease Srpski Arhiv Za Celokupno Lekarstvo 121(1-2): 20-21
Dusilová Sulková, S. 2011: Bone disease in chronic renal failure and its modern therapy Vnitrni Lekarstvi 57(7-8): 620-625
Hadzijahić, H. 1982: Internal medicine aspects of the modern therapy of ulcer disease Medicinski Arhiv 36(5-6): 279-285
Klivényi, Péter.; Vécsei, László. 2007: Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease Ideggyogyaszati Szemle 60(1-2): 61-64
Yanagawa, Y.; Ogura, M.; Okuda, E.; Okunaga, T.; Takahata, H.; Nakamura, M. 2003: A case of moyamoya disease diagnosed by cerebral ischemic symptoms induced by anti-hypertensive therapy No Shinkei Geka. Neurological Surgery 31(3): 275-279
Möller, J.C.; Sautter, J.; Kupsch, A. 1996: Potential of neurotrophic factors in therapy of Parkinson's disease Journal of Neural Transmission. Supplementum 48: 103-112
Katunina, E.A. 2005: Estimating the potential of antioxidant therapy for patients with Parkinson's disease diagnosis Eksperimental'naia i Klinicheskaia Farmakologiia 68(5): 16-18
Liu, T.T.; Li, Y.; Yao, S.Y.; Wang, C.; Wang, M.; Liu, J.; Shi, Y.J.; Xue, H. 2019: Effect of individualized antihypertensive therapy on the blood pressure and left ventricular hypertrophy of hypertensive patients with coronary heart disease Zhonghua Yi Xue Za Zhi 99(13): 977-982
Xiao, X.; Ma, X.; Liu, L.; Wang, J.; Bi, K.; Liu, Y.; Fan, R.; Zhao, B.; Chen, Y.; Bihl, J.C. 2015: Cellular Membrane Microparticles: Potential Targets of Combinational Therapy for Vascular Disease Current Vascular Pharmacology 13(4): 449-458
Fallon, B.; Foote, B.; Walsh, B.T.; Roose, S.P. 1988: 'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors Journal of Clinical Psychiatry 49(4): 163-165
Martens, L.L.; Guibert, R. 1994: Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease Clinical Therapeutics 16(6): 1052-62; discussion 1036
Safar, M.E.; Laurent, S.L.; Bouthier, J.D.; London, G.M.; Mimran, A.R. 1986: Effect of converting enzyme inhibitors on hypertensive large arteries in humans Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 4(5): S285-S289
Zdrojewicz, Z.; Konieczny, R.ła.; Papier, P.; Szten, F. 2015: Brdt Bromodomains Inhibitors and other Modern Means of Male Contraception Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University 24(4): 705-714
Tamura, K.; Yutoh, J.; Matsushita, K.; Sakai, M.; Oshikawa, J. 2015: Hypertension with chronic kidney disease: anti-hypertensive therapy recommended for the management of hypertension with CKD in JSN-CKD GL 2013 and JSH2014 Nihon Rinsho. Japanese Journal of Clinical Medicine 73(11): 1876-1884